Vaccine shows promise in curing HIV, Hong Kong biotech start-up says

Quick Summary:

We may be on the brink of a breakthrough,’ Dr Edward Leong, advisory board chairman of Immuno Cure says.

Data from the first-phase trial will be submitted to regulatory agencies for review.

Forty-five people took part in the trial.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Xinmei Shen

Category: Business

Markets: Hong KongPakistan

Topics: Clinical Cure First-phase Company Therapeutic Trial Cells Icvax Kong Immuno Hong

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-14 @ 17:00:09 (2 hours ago)

News Timezone: GMT +8:00

News Source URL: scmp.com

Language: English

Article Length: 190 words

Reading Time: 2 minutes read

Sentences: 10 lines

Sentence Length: 19 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © SCMP

News ID: 23582981

View Article Analysis

About SCMP

Main Topics: Business

Official Website: scmp.com

Update Frequency: 10 posts per day

Year Established: 1903

Headquarters: Hong Kong

News Last Updated: 2 hours ago

Coverage Areas: Hong Kong

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #42

Publisher Details

Frequently Asked Questions